Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.93 +0.03 (+3.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Amortizatization of Intangibles (2010 - 2024)

Updated

Lineage Cell Therapeutics (LCTX) posted Amortizatization of Intangibles of $22,000 for FY2024, down 83.1% from $130,000 in FY2023.

Analysis

Lineage Cell Therapeutics (LCTX) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends

Since FY2010, Lineage Cell Therapeutics has reported Amortizatization of Intangibles for 15 years.

  • Annual Amortizatization of Intangibles has declined for ten consecutive years, with a five-year compound annual growth rate of -59.4% (FY2019 to FY2024).
  • The FY2024 figure stands as the lowest annual Amortizatization of Intangibles in data going back to FY2010.
  • Business Quant data shows LCTX's Amortizatization of Intangibles at $130,000 in FY2023 (-10.3%), $145,000 in FY2022 (-31.0%), $210,000 in FY2021 (-82.7%) and $1.22 million in FY2020 (-39.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lineage Cell Therapeutics 235.20 Mn 33.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 22,000.00
Dec 31, 2023 32,000.00
Sep 30, 2023 33,000.00
Jun 30, 2023 32,000.00
Mar 31, 2023 33,000.00
Dec 31, 2022 32,000.00
Sep 30, 2022 48,000.00
Jun 30, 2022 32,000.00
Mar 31, 2022 28,000.00
Dec 31, 2021 32,000.00
Sep 30, 2021 33,000.00
Jun 30, 2021 33,000.00
Mar 31, 2021 112,000.00
Dec 31, 2020 136,000.00
Sep 30, 2020 250,000.00
Jun 30, 2020 333,000.00
Mar 31, 2020 498,000.00
Dec 31, 2019 498,000.00
Sep 30, 2019 508,000.00
Jun 30, 2019 507,000.00
API Access

Lineage Cell Therapeutics Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=LCTX&period=max&api_key=YOUR_API_KEY